137 related articles for article (PubMed ID: 25325525)
1. Avoiding patient morbidity: Updated statin drug interactions and risks for patient harm.
Finks SW; Campbell JD
Nurse Pract; 2014 Nov; 39(11):45-51. PubMed ID: 25325525
[TBL] [Abstract][Full Text] [Related]
2. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
Alford JC; Saseen JJ; Allen RR; Nair KV
Pharmacotherapy; 2012 Jul; 32(7):623-30. PubMed ID: 22570173
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin interactions with other drugs.
Florentin M; Elisaf MS
Expert Opin Drug Saf; 2012 May; 11(3):439-44. PubMed ID: 22416996
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians.
Kerr KP; Mate KE; Magin PJ; Marley J; Stocks NP; Disler P; Pond CD
J Clin Pharm Ther; 2014 Aug; 39(4):383-9. PubMed ID: 24702306
[TBL] [Abstract][Full Text] [Related]
6. Does simvastatin cause more myotoxicity compared with other statins?
Backes JM; Howard PA; Ruisinger JF; Moriarty PM
Ann Pharmacother; 2009 Dec; 43(12):2012-20. PubMed ID: 19920157
[TBL] [Abstract][Full Text] [Related]
7. Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2004 Jun; 93(11):1417-8, A9. PubMed ID: 15165929
[TBL] [Abstract][Full Text] [Related]
8. New simvastatin dosing recommendations.
Med Lett Drugs Ther; 2011 Aug; 53(1370):61-2. PubMed ID: 21836544
[No Abstract] [Full Text] [Related]
9. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
[TBL] [Abstract][Full Text] [Related]
10. [Interactions between statins and macrolide antibiotics].
Molden E; Andersson KS; Jacobsen D
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1660-1. PubMed ID: 17571108
[No Abstract] [Full Text] [Related]
11. Fixed-dose combination therapy with statins: strengths, limitations, and clinical and regulatory considerations.
Hennekens CH
Am J Cardiovasc Drugs; 2008; 8(3):155-60. PubMed ID: 18533736
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin.
Page SR; Yee KC
Intern Med J; 2014 Jul; 44(7):690-3. PubMed ID: 25041770
[TBL] [Abstract][Full Text] [Related]
13. Team-based approach to addressing simvastatin safety concerns.
Robinson M; Gunning K; Pippitt K; McAdam-Marx C; Jennings BT
J Am Pharm Assoc (2003); 2013; 53(5):539-44. PubMed ID: 24030132
[TBL] [Abstract][Full Text] [Related]
14. Statin safety and drug interactions: clinical implications.
Bottorff MB
Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
18. Statin safety: lessons from new drug applications for marketed statins.
Jacobson TA
Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.
Hsyu PH; Schultz-Smith MD; Lillibridge JH; Lewis RH; Kerr BM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3445-50. PubMed ID: 11709322
[TBL] [Abstract][Full Text] [Related]
20. Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
Prom R; Umscheid CA; Kasbekar N; Spinler SA
Am J Health Syst Pharm; 2013 Nov; 70(21):1878-9. PubMed ID: 24128959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
